We were delighted to be part of the 14th Annual Pharma IPR India Conference in Mumbai, where discussions around biologics and the evolving landscape of the Indian pharmaceutical industry took center stage. Suvarna Pandey, Associate Partner from our team participated in the conference.

India, often referred to as the “pharmacy of the world,” plays a critical role in global healthcare, with its pharmaceutical industry spanning generic drugs, OTC medicines, bulk drugs, vaccines, contract research, biosimilars, and biologics. The presence of industry experts made for insightful discussions on innovation, challenges, and the role of intellectual property in shaping the future of pharma.

We look forward to continuing the conversation and contributing to advancements in the industry!